Title

Rapid review: nonsteroidal anti-inflammatory agents and aminosalicylates in COVID-19 Infections

Abstract

In the current COVID-19 pandemic, there has been concern regarding the use of ibuprofen and other nonsteroidal anti-inflammatory agents by COVID-19 infected patients. Aminosalicylates (5-ASAs) are structurally similar and have anti-inflammatory functions that resemble those of nonsteroidal anti-inflammatory agents. Since 5-ASAs are a mainstay treatment for inflammatory bowel disease, the authors review the pharmacology of both classes of drugs and discuss the potential relevance of 5-ASAs in the ongoing discussion of medication use in patients infected with COVID-19.

Document Type

Article

PubMed ID

32530870

DOI

10.1097/MCG.0000000000001371

Link to Full Text

 

Share

COinS